ApaTech Limited, a world leader in synthetic bone graft material, provides surgeons with superior, proprietary, bone graft solutions, helping them improve clinical outcomes and patient quality of life.

ApaTech was built around technology developed at Queen Mary University of London and was established in 2001 with an investment by 3i. Since 2001 the Company has relocated to bespoke manufacturing facilities in Elstree, established a US subsidiary in Massachusetts, and launched its gold standard product Actifuse in over 20 countries. It is currently on a 300% year-on-year growth trajectory with sales of over £3m in 2007.

In September 2007, ApaTech was recognised as the fastest growing private medical technology company in the Sunday Times 2007 Tech Track 100.

Dr. David Holbrook, who led the deal for MTI, is on the board of ApaTech.

www.apatech.com